Belluscura’s Portable Oxygen Concentrator Cleared for US Market
X-PLO₂R, a portable oxygen concentrator developed by Belluscura and its research partner Separation Design Group, has been cleared for commercialization in the U.S. The Food and Drug Administration (FDA) cleared the company’s premarket notification, or 510(k), and granted marketing authorization to the new device. Premarket notification is a formal…